Clinical trials
Phase 2 Lung Diseases trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2021 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 4 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Complexa, Inc. | 2 |
| Eli Lilly and Company | 2 |
| Upstream Bio Inc. | 2 |
| Altesa Biosciences, Inc. | 1 |
| Celgene | 1 |
| Insmed Incorporated | 1 |
| Iovance Biotherapeutics, Inc. | 1 |
| Mereo BioPharma | 1 |
| NovaBiotics Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases | 21 |
| Respiratory Tract Diseases | 11 |
| Asthma | 5 |
| Bronchial Diseases | 3 |
| Carcinoma | 3 |
| Cardiovascular Diseases | 3 |
| Emphysema | 3 |
| Hypertension, Pulmonary | 3 |
| Lung Neoplasms | 3 |
| Pulmonary Disease, Chronic Obstructive | 3 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.